For the Inventor, By the Inventor

Enter assignee name

Marcy l'Etoile, France

Biomerieux Sa

USPTO Granted Patents = 82

% Expired Patents = 39.0

CIPO Patents = 6

EPO Patents = 28

Trademarks = 4

Forward Citations = 399

Loading Chart...

Loading Chart...

179 inventors (with patents filed for the assignee):

Bruno Colin (13 out of 72 patents)

Sylvain Orenga (11 out of 35 patents)

Arthur James (9 out of 23 patents)

4. John Perry (7 out of 20 patents)

5. Steven T Brentano (6 out of 56 patents)

6. Patrick Pouteau (6 out of 31 patents)

7. Vindhya Salwatura (6 out of 8 patents)

8. Stephen Stanforth (6 out of 10 patents)

9. Philippe L Cleuziat (5 out of 17 patents)

10. Stefan Miller (4 out of 25 patents)

11. Antoine Vimont (4 out of 9 patents)

12. David Mosticone (4 out of 11 patents)

13. Laurent Drazek (4 out of 15 patents)

14. Patrick Broyer (4 out of 18 patents)

15. Olivier Fabrega (4 out of 6 patents)

Core Competencies:

Microbiological Testing

Assay Devices

Nucleic Acid Amplification

Detection Methods

Biological Samples

Mass Spectrometry

Fluorescent Probes

Antibodies

Enzymatic Substrates

HIV Detection

Bacterial Identification

Immunological Tests

82 patents: Sort by Forward Citations

1. 12698518 - PROCESS OF DIRECTLY DETECTING AND IDENTIFYING A MICROORGANISM IN A BIOLOGICAL SAMPLE DILUTED IN AN ENRICHMENT BROTH (2026-08-04),

2. 12172169 - Assay devices and methods of use thereof (2024-12-24),

3. 11691152 - Assay devices and methods of use thereof (2023-07-04),

4. 11623213 - Microbiological testing device, method for provision and use of such a device (2023-04-11),

5. 10907190 - Process of directly detecting and identifying a microorganism in a biological sample diluted in an enrichment broth (2021-02-02),

6. 10829825 - Detection of mecA variant strains of methicillin-resistant (2020-11-10),

7. 10494658 - Medium for the specific detection of resistant microorganisms (2019-12-03),

8. 10441952 - Device for preparing and/or treating a biological sample (2019-10-15),

9. 10408841 - Mutated HEV polypeptides and the use thereof for assaying anti-HEV antibodies (2019-09-10),

10. 10077461 - Method for characterizing at least one microorganism by means of mass spectrometry (2018-09-18),

11. 9777317 - Microfluidic PCR device (2017-10-03),

12. 9707554 - Simplified device for nucleic acid amplification and method for using same (2017-07-18),

13. 9650662 - Method of sampling and/or depositing a sample of biological matter and device implementing such a method (2017-05-16),

14. 9528990 - Fluorogenic/fluorescent probes derivative from sulfoxanthene, and use thereof (2016-12-27),

15. 9394573 - [object Object] (2016-07-19),

Company Overview

Biomerieux Sa, headquartered in Marcy l'Etoile, France, specializes in microbiological testing solutions that enhance diagnostic accuracy in healthcare. The company develops and manufactures a range of assay devices and detection methods, focusing on nucleic acid amplification and mass spectrometry technologies. Their innovations support the analysis of biological samples through advanced techniques, including the use of fluorescent probes and antibodies, positioning Biomerieux as a leader in the field of in vitro diagnostics.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

82 Patents

#1 in Marcy l'Etoile

#323 in France

#9,264 in the World

Marcy l'Etoile, France

Biomerieux Sa

Forward Citations = 399

179 inventors:

Bruno Colin (13 out of 72 patents)

Sylvain Orenga (11 out of 35 patents)

Arthur James (9 out of 23 patents)

4. John Perry (7 out of 20 patents)

5. Steven T Brentano (6 out of 56 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biomerieux Sa. Retrieved from https://idiyas.com/company/biomerieux-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…